One way or another, many of us are using various devices and screens for many hours of the day through working from home or in our leisure time. Spending long periods looking at computer, phone, or tablet screens can strain the eyes. Using the 20-20-20 rule can help to prevent this problem.
The rule says that for every 20 minutes spent looking at a screen, a person should look at something 20 feet away for 20 seconds. Read more:
https://www.medicalnewstoday.com/articles/321536
We are all being advised to take exercise once a day and this is particularly important for people with diabetes as the treatment of both types of diabetes is medication (whether insulin or tablets) diet and exercise.
Click here for advice and some exercises to get you started
Some of our members sponsor children and young people at the Dream Trust in Nagpur, India and they will be concerned about the health and wellbeing of these vulnerable young people as a result of the lockdown in India.
This article emphasises his advice that they should not lower their insulin doses because of fears of lack of availability of insulin. This link provides you with te English translation of Dr Pendsey’s newspaper article offering advice to families.
Our booklet, ‘Diabetes – Everyday Eating’ provides menus for breakfast, lunch and evening meal for 28 days. The menus are for everyday eating, so ideal for this difficult time when sometimes we can only buy essential items.
As we have lots of time on our hands at the moment, now might be the time to try something different to eat! You can access this booklet on our website at: https://www.iddt.org/wp-content/uploads/2011/10/A4_Health_Nutrition_Booklet.pdf
Brexit and insulin supplies
As most people are aware, all human and analogue insulins are made outside the UK and only pork insulin is made in the UK. It is understandable that people have concerns about insulin supplies as a result the UK leaving the European Union (Brexit). The insulin manufacturers have stated that they already have stockpiles in the UK and this is more than the normal 6 weeks’ supply recommended by the Government. They have also set up alternative delivery routes into the UK.
They are urging people not to stockpile insulin or any other diabetes medication, themselves because this disrupts supplies for everyone and could put some people at risk of not being able to get their insulin. However, it is recommended that people reorder their insulin and other medicine supplies early in case there are local delays.
Reassurances from the Royal Pharmaceutical Society have issued a statement to confirm that “protecting patient care, supporting the pharmacy workforce, and ensuring the continuity of medicines supply will continue to be high priorities for 2021…”Having sought and received assurances from the UK Government, devolved governments, the pharmaceutical industry and others on plans to sustain the supply of medicines following the Brexit transition period while we will continue to monitor the situation in the short-term, the organisation’s focus for 2021 will be on the medium to long-term plans for pharmaceutical care.”
Post Brexit changes
Perhaps it is difficult to see at the present time, but there will come a time when we can safely travel abroad again. We are all aware that the UK has left the EU but because of the pandemic, perhaps we are not as aware of the changes as we would otherwise have been…
The changes affect us all, but some are particularly important for people with long-term health conditions, such as diabetes, so below is a brief outline of the key changes.
Health insurance
EHIC and GHIC – for travel within most European countries we have previously had a free European Health Insurance Card (EHIC). This remains valid until it runs out and then you have to apply for a free Global Health Insurance Card (GHIC). Just like an EHIC, it is possible to apply for this new card on behalf of yourself, but also your spouse/ partner, your children (under 16) and other family members. However, you and each person on the application must meet the nationality and residency conditions which basically are focused on making sure that you and they are UK citizens.
You get a GHIC card by applying on the NHS website: https://www.nhs.uk/using-the-nhs/healthcare-abroad/apply-for-a-free-ehic-european-health-insurance-card/ Be aware that there are some websites that try to ‘sell’ these cards, so do not fall for this, the official cards are free.
A still valid EHIC or the new GHIC enables you to benefit from prompt, largely free health services in the 27 countries which are part of the European Union but from 1st January 2021, neither a GHIC nor most EHICs will cover you in Norway, Iceland, Liechtenstein or Switzerland. When visiting these countries, you must make sure your travel insurance covers you for healthcare cover.
NOT a replacement for travel insurance – it is important to remember that the GHIC (or valid EHIC) is NOT an alternative to travel insurance. It helps you to access types of healthcare quickly and usually free at the point of delivery but not all countries offer the same free services that you would receive on the NHS so you could have to pay for some services. In addition, travel insurance is still needed for many reasons including getting you home following an injury, illness or specialist treatment for existing health conditions, such as diabetes.
Just a reminder too, that you need to check that any travel insurance you take out, does cover your pre-existing health conditions and this is not always the case with insurance offered by travel agents.
Passports
One of our Type 1 members phoned today to warn other people of his experience with the DVLA online driving licence application.
Diabetes care in nursing homes still remains “fragmented” and urgent steps need to be taken to restore the “health and dignity” of older people, leading experts have said.
A review of multiple studies carried out across 25 years involving residents with diabetes has slammed care home provision saying that care homes “often do not meet national standards” of diabetes care and staff training is “patchy”.
Lead author Professor Alan Sinclair, from the Foundation for Diabetes Research in Older People and University of Aston, said: “Our findings show the level of diabetes care remains fragmented which is quite worrying because figures suggest over a quarter of care home residents are believed to have the condition. Without proper management, it can lead to frailty, dependency, disability and reduced life expectancy.
Meter for the visually impaired removed from the market
The SuperCheck2 blood glucose meter for visually impaired people has been withdrawn from the market by the manufacturer, Apollo Medical Technologies Ltd. This meter provided blood glucose readings through a voice system.
There is another glucose meter on the market to help visually impaired people with diabetes, the GlucoRx Nexus Voice Meter. This meter uses GlucoRx Nexus test strips and GlucoRx Nexus Lancets.
“The number of adults and older teens with diabetes in the UK has more than doubled over the past 20 years, with 3.7 million people aged 17 or older now known to be living with the disease, campaigners say.”
From January 2018 IRN-BRU will contain approximately 50% less sugar. The sugar content per 100ml will reduce from 10.3g to 4.7g. For a time old and new products may be on the shelf together so remember to check the label.
People with diabetes should be aware of the carbohydrate content change and should seek medical advice.
Please click the image to zoom in for all of the info.
From December 2018, people in the US will not be able to import pork insulin from Wockhardt UK.
This is due to stringent Regulatory Controls, leaving Wockhardt UK with no choice but to discontinue the supply of Hypurin Porcine & Bovine insulin which is directly supplied to the patients in the USA on a “Name Patient basis”.
On November 30th 2018, Wockhardt issued the following statement which offers reassurance to people in the UK who use Hypurin® porcine insulin…
neuropad® is a patented 10-minute screening test for the early detection of diabetic foot syndrome; a condition which can lead to serious complications such as foot ulceration and even amputation. The test is completely painless. Think of the test as an early warning system for your feet.
List of published clinical studies: http://www.neuropad.co.uk/case-studies/
The price of the test comprising of two test pads is £14.99, no VAT payable and can be purchased from our website shop, or by phoning IDDT on 01604 622837.
The term ‘pre-diabetes’ has crept into our language and there is debate about its use. People who are at risk of developing Type 2 diabetes are now being classed as having ‘pre-diabetes’ or ‘borderline diabetes’.
IDDT now sell diabetes-friendly socks in our online shop. Our Comfort Socks have been developed for use by people with diabetes, vascular disorders and other circulatory problems. Our Fuller Fitting Longer Sock is for people who find it difficult to wear ordinary socks. These are made with a large circumference top and are suitable for people who may be suffering from oedema (swollen legs), for example.
The Comfort Socks retail at £8 and the Fuller Fitting at £12 per pair including p&p. To order your socks, please visit our online shop, or phone IDDT on 01604 622837.
This is the title of a report issued by the Parliamentary and Health Ombudsman on October 20th 2016 and the title page describes it as ‘How drivers have been let down by the Driver and Vehicle Licensing Agency (DVLA)’.
Several new insulins have come to the market recently; three high strength insulins which have concentrations greater than the previously standard strength of U100 and biosimilar insulin.
The Trustees of IDDT have discussed the introduction of different strengths of insulin in depth and strongly expressed their concerns about the risks of errors by people with diabetes, health professionals and hospitals. These concerns come from their experiences of the introduction of the first genetically modified human insulin in the 1980s when there was a dearth of evidence of benefit and many people with diabetes were not informed of the differences from their previous natural animal insulin.
The European Medicines Agency (EMA) has started a review of canagliflozin, dapagliflozin and empagliflozin, which are diabetes medicines known as SGLT2 inhibitors. This was requested by the European Commission following several reports of diabetic ketoacidosis in patients on SGLT2 inhibitor treatment for Type 2 diabetes. EMA will now review all available data on the risk of diabetic ketoacidosis (DKA) with SGLT2 inhibitors and consider whether any changes are needed in the way these medicines are used in the EU.
Please show your support by joining IDDT or renewing your membership now.
We rely on voluntary donations and appreciate any help you can give.
Find out the great benefits of becoming a member.
IDDT has a CONFIDENTIAL Helpline,
find out more.
You don’t have to be a member to donate, you can use the button below to donate via a secure PayPal Donation form. Thank you.
All the money that we raise through the IDDT Lottery goes directly to help people with diabetes and their families.
Find out more.
NICE is an independent organisation responsible for providing national guidance on promoting good health.
InDependent Diabetes Trust
PO Box 294
Northampton
NN1 4XS
UK
01604 622837
An umbrella organisation
All IDDT publications are now accessible via the main Publications menu at the top of the page
